Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.240
+0.030 (1.36%)
At close: Feb 21, 2025, 4:00 PM
2.170
-0.070 (-3.13%)
After-hours: Feb 21, 2025, 5:31 PM EST
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $192.71 million as of February 21, 2025. Its market cap has decreased by -1.23% in one year.
Market Cap
192.71M
Enterprise Value
133.87M
1-Year Change
-1.23%
Ranking
Category
Stock Price
$2.24
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $192.71M, an increase of 53.90%. That is a compound annual growth rate of 3.71%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 779.91B |
| UnitedHealth Group | 464.24B |
| Johnson & Johnson | 379.69B |
| Novo Nordisk | 365.53B |
| AbbVie | 348.56B |
| AstraZeneca | 230.61B |
| Abbott Laboratories | 228.72B |
| Intuitive Surgical | 216.51B |